Literature DB >> 10770415

Comparing quality of life following liver transplantation for Laennec's versus non-Laennec's patients.

T Cowling1, L W Jennings, G S Jung, R M Goldstein, E Molmenti, T A Gonwa, G B Klintmalm, M F Levy.   

Abstract

The overall success of orthotopic liver transplantation (OLTX) includes not only survival, but quality of life (QOL) as well. We studied one controversial group of OLTX recipients, patients transplanted for alcoholic liver disease (Laennec's), to determine if their post-OLTX QOL was similar to that of patients transplanted for non-alcoholic liver disease (non-Laennec's). Over a 10-yr period, patients undergoing OLTX at our institution were asked to complete a QOL questionnaire addressing a wide range of topics from demographics and employment to symptom distress/frequency, activities of daily living, and effect of loss of health on daily life. Twenty-four Laennec's and 100 non-Laennec's OLTX recipients completed the questionnaire at both their 2- and 5-yr follow-up visits at our institution. Both groups were well-matched in age, race, and patient location status at the time of OLTX. No significant differences could be detected between Laennec's and non-Laennec's scores regarding overall QOL, including one's ability to function, health perception, and self-perception at 2 and 5 years post-OLTX, and between 2 and 5 years post-OLTX. Although not between groups, a significant difference was noted regarding patients' satisfaction with life, with less satisfaction reported at the 5-yr versus the 2-yr time point post-OLTX. Rates of current/recent employment between both groups were also similar at 2 years post-OLTX, and again at 5 years post-OLTX. We conclude that overall QOL and employment levels appear similar between patients transplanted for alcoholic and non-alcoholic liver disease. This similarity appears to extend to 5 years post-OLTX.

Entities:  

Mesh:

Year:  2000        PMID: 10770415     DOI: 10.1034/j.1399-0012.2000.140203.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  3 in total

Review 1.  Calcineurin signaling as a target for the treatment of alcohol abuse and neuroinflammatory disorders.

Authors:  Patrick J Ronan; Sarah A Flynn; Thomas P Beresford
Journal:  Prog Mol Biol Transl Sci       Date:  2019-08-12       Impact factor: 3.622

Review 2.  Measuring patient-reported outcomes in solid organ transplant recipients: an overview of instruments developed to date.

Authors:  Irina Cleemput; Fabienne Dobbels
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Societal reintegration after liver transplantation: findings in alcohol-related and non-alcohol-related transplant recipients.

Authors:  Terianne Cowling; Linda W Jennings; Robert M Goldstein; Edmund Q Sanchez; Srinath Chinnakotla; Goran B Klintmalm; Marlon F Levy
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.